BioNTech SEBNTXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank38
3Y CAGR-17.6%
5Y CAGR-14.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-17.6%/yr
Annual compound
5Y CAGR
-14.6%/yr
Consistent
Percentile
P38
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 26.42% |
| 2023 | 16.01% |
| 2022 | 61.93% |
| 2021 | 47.16% |
| 2020 | 184.77% |
| 2019 | 58.32% |
| 2018 | 67.34% |
| 2017 | 0.00% |
| 2016 | 0.00% |